Published in Am J Addict on September 12, 2006
Motivational Interviewing to Reduce Substance Use Among Depression Patients | NCT02420561
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Neural correlates of reward processing in adults with 22q11 deletion syndrome. J Neurodev Disord (2016) 1.40
Ethical issues in mental health research: the case for community engagement. Curr Opin Psychiatry (2011) 1.13
Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology (2011) 0.89
Childhood onset diagnoses in a case series of teens at clinical high risk for psychosis. J Child Adolesc Psychopharmacol (2009) 0.86
Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Hum Genet (2011) 0.86
Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders. Addict Behav (2009) 0.82
Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: the Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 Weeks (LSUR-12) Instruments. J Psychiatr Res (2010) 0.81
Reasons for illicit drug use in people with schizophrenia: Qualitative study. BMC Psychiatry (2010) 0.81
Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders. BMC Psychiatry (2014) 0.80
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry (2015) 0.79
Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat (2015) 0.77
Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia. Schizophr Res (2008) 0.76
Illicit drug use in heavy smokers with and without schizophrenia. Schizophr Res (2012) 0.76
Risk-taking in schizophrenia and controls with and without cannabis dependence. Schizophr Res (2014) 0.76
Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia. Am J Drug Alcohol Abuse (2009) 0.75
Antipsychotic treatment of adolescent dual diagnosis patients. J Pediatr Pharmacol Ther (2011) 0.75
Comorbid substance use disorders in schizophrenia: a latent class approach. Psychiatry Res (2014) 0.75